Scientists crack how aspirin might stop cancers from spreading

Terminology and What “Aspirin” Means

• Some commenters object to the article using “aspirin” instead of “acetylsalicylic acid (ASA),” arguing modern tablets are mixtures with fillers, binders, coatings, and sometimes other actives (e.g., caffeine).
• Others respond that in common and regulatory usage “aspirin” essentially means ASA, and that “acetylsalicylic acid” would confuse most readers.
• There’s brief side discussion on tablet composition, pill size vs active mass, and brand combinations being casually called “aspirin.”

Mechanism: Platelets, T‑cells, and Metastasis

• A quoted summary: platelets suppress T‑cells that would otherwise attack metastasizing cancer cells; aspirin inhibits platelet function, lifting this suppression.
• Several readers praise this as a clear explanation and note it reframes aspirin’s effect as immune‑modulating rather than “mysteriously anti-cancer.”
• One asks whether people with naturally low platelets have better cancer outcomes; others think it’s an important but currently unanswered question.

Mice vs Humans and Existing Human Data

• Some criticize the coverage for not foregrounding that the new mechanistic work is in mice.
• Others note earlier human studies suggesting reduced metastasis with aspirin and say the new paper clarifies “how,” not “if,” at least mechanistically.
• There is mention of ongoing human trials (e.g., Add‑Aspirin), but commenters stress that this is not yet standard-of-care guidance.

Self-Medication, Risk–Benefit, and Side Effects

• One camp argues that patients with serious cancer might reasonably start low‑dose aspirin now, given the stakes, after reading about side effects and informing their doctor.
• Another camp pushes back hard: aspirin increases bleeding risk (GI bleeds, hemorrhagic stroke), may interact with other treatments, and population‑level data show little or negative net benefit for routine use in people without cardiovascular disease.
• Several anecdotes describe nosebleeds or rectal bleeding resolving after stopping daily aspirin, reinforcing that harms are real.

Formulations and Stomach Protection

• There is a brief, contentious tangent about enteric‑coated aspirin versus plain aspirin combined with vitamin C, DGL, or collagen to protect the stomach; others dismiss this as off-topic or fringe.

Alternative Health and Ray Peat Debate

• A sizeable subthread debates a niche online health community that has long promoted aspirin.
• Critics label its leading figure a “quack,” citing extreme claims (e.g., about specific foods), cherry‑picked animal studies, and overgeneralization.
• Defenders argue his work is misrepresented, urge reading primary sources, and note that some of his ideas (e.g., about aspirin, nicotine) overlap with emerging or ongoing research.
• Meta-discussion follows on how quackery often mixes plausible ideas with unsupported or exaggerated ones, and how followers may selectively highlight “hits” while ignoring “misses.”

Broader Reflections: Evolution and Future Medicine

• Some commenters muse that strong clotting and energy conservation were adaptive historically but may be maladaptive in modern environments, and speculate that gene editing and personalized, AI-guided biochemistry could eventually “re-tune” human physiology.
• Others counter that evolution hasn’t stopped, just slowed and diffused due to weaker selective pressures and modern medicine.